This conference stands as a landmark event for the Botton-Champalimaud Pancreatic Cancer Centre in 2024 and will unite leading minds in translational science, oncology and surgery to tackle the complexities of pancreatic cancer.

The conference will serve as a pivotal platform for the exchange of groundbreaking insights, state-of-the-art surgical methodologies, and innovative therapeutic approaches that will ultimately enhance patient care and outcomes on a global scale.

Rita Fior, leader of the Cancer Development and Innate Immune Evasion Group at the Champalimaud Foundation (CF), has been studying for several years the power of zebrafish “avatars”, or zAvatars, of cancer patients to help guide therapeutic decisions. The goal: to predict individual cancer treatment outcomes, thus enabling the selection of the best available chemotherapy treatment for each patient.

Getting Doctors and Technologists to Talk About Artificial Intelligence

On the occasion of the Artificial Intelligence Appreciation Day, a conference will be held at the Champalimaud Foundation aimed at bridging the gap between AI innovation and its implementation in medical practice.

The goal of the MEDICA AI - The Conference, which will take place on July 16 at the Champalimaud Foundation (FC), is to familiarise healthcare professionals, with the latest AI tools so that they can apply them in their daily practice for the benefit of patients.